Aspen Aerogels, Inc. (NYSE:ASPN) Receives $28.70 Consensus Target Price from Analysts

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have received a consensus rating of “Buy” from the nine brokerages that are currently covering the firm, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is $30.00.

Several analysts recently weighed in on ASPN shares. HC Wainwright reaffirmed a “buy” rating and issued a $30.00 target price on shares of Aspen Aerogels in a report on Wednesday, October 16th. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a research note on Wednesday, November 13th. Roth Mkm cut their price target on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. Barclays lowered their price objective on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research report on Tuesday, November 12th. Finally, Piper Sandler dropped their price objective on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd.

Institutional Investors Weigh In On Aspen Aerogels

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Driehaus Capital Management LLC boosted its stake in Aspen Aerogels by 130.4% during the 2nd quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock worth $51,439,000 after purchasing an additional 1,220,724 shares during the period. FMR LLC boosted its stake in shares of Aspen Aerogels by 23.6% during the third quarter. FMR LLC now owns 4,050,896 shares of the construction company’s stock worth $112,169,000 after buying an additional 773,647 shares during the period. American Century Companies Inc. grew its holdings in shares of Aspen Aerogels by 562.3% during the second quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock worth $18,382,000 after buying an additional 654,350 shares during the last quarter. Millennium Management LLC acquired a new position in Aspen Aerogels in the 2nd quarter valued at about $9,339,000. Finally, Lord Abbett & CO. LLC purchased a new stake in Aspen Aerogels during the 3rd quarter valued at approximately $10,126,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Price Performance

ASPN stock opened at $11.88 on Thursday. The business’s 50-day moving average is $14.72 and its two-hundred day moving average is $21.31. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The firm has a market capitalization of $974.72 million, a P/E ratio of 1,189.19 and a beta of 2.12. Aspen Aerogels has a 1 year low of $10.75 and a 1 year high of $33.15.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.